NCM
HURA

Nantahala Capital Management’s TuHURA Biosciences HURA Stock Holding History

Nantahala Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,279
Closed -$15.6K – 150
2024
Q3 		$15.6K Buy
+2,279
New +$17K ﹤0.01% 138
2024
Q2 		– Sell
-365
Closed -$1.28K – 144
2024
Q1 		$1.28K Sell
365
-264
-42% -$1.06K ﹤0.01% 123
2023
Q4 		$3.73K Sell
629
-17
-3% -$879 ﹤0.01% 128
2023
Q3 		$91.4K Buy
+646
New +$95.3K 0.01% 126
2023
Q1 		– Sell
-340
Closed -$82K – 131
2022
Q4 		$82K Hold
340
– – 0.01% 112
2022
Q3 		$64K Buy
340
+274
+415% +$87.6K ﹤0.01% 113
2022
Q2 		$32K Sell
66
-313
-83% -$136K ﹤0.01% 120
2022
Q1 		$264K Hold
379
– – 0.01% 112
2021
Q4 		$338K Hold
379
– – 0.01% 125
2021
Q3 		$582K Buy
379
+80
+27% +$210K 0.02% 120
2021
Q2 		$1.19M Sell
299
-217
-42% -$623K 0.03% 111
2021
Q1 		$1.57M Buy
516
+360
+231% +$1.22M 0.05% 106
2020
Q4 		$349K Buy
+156
New +$391K 0.01% 111

Other funds holding HURA

Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Nantahala Capital Management's HURA Position: Q4 2024 in Review

Nantahala Capital Management sold out of TuHURA Biosciences (HURA) in Q4 2024, closing a stake of 2,279 shares — an estimated $15.6K sold.

Nantahala Capital Management first reported a position in HURA in Q4 2020 and held it in 13 quarters. The position peaked at $1.57M in Q1 2021. 27 funds tracked by Wall St. Rank hold HURA as of Q4 2024.

  • Nantahala Capital Management reported no remaining TuHURA Biosciences position as of Q4 2024 after selling out during the quarter.
  • Nantahala Capital Management sold 2,279 TuHURA Biosciences shares in Q4 2024, an estimated $15.6K.
  • Nantahala Capital Management first reported a position in TuHURA Biosciences in Q4 2020 and held it in 13 quarters.
  • Nantahala Capital Management's TuHURA Biosciences position peaked at $1.57M in Q1 2021.
  • 27 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.